Clinical Trial

A Study of A-CAR028 Treatment in Subjects With Relapsed or Refractory Acute Myeloid Leukemia

Name: A Study of A-CAR028 Treatment in Subjects With Relapsed or Refractory Acute Myeloid Leukemia — clinical trial record (NCT07198867)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a single-center, open-label study to evaluate the safety and efficacy of A-CAR028 in relapsed/refractory acute myeloid leukemia patients

Trial Details

NCT Number	NCT07198867
Lead Sponsor	First Affiliated Hospital of Zhejiang University Collaborators: Shanghai AbelZeta Ltd.
Conditions	Acute Myeloid Leukemia (AML), CAR-T Cell Therapy
Enrollment	20 participants
Start Date	2025-09-30
Primary Completion	2026-12-30 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-09-30